Search Knowledge Base

23 results for "factor-x"

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2025 PMID: 39868562
Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38770962
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 36814196
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism pubmed_article
Evidence Source 2023 PMID: 37057837
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis pubmed_article
Evidence Source 2023 PMID: 37058421
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 37419006
Vitamin K antagonist reversal strategies: Systematic review and network meta-analysis from the AABB pubmed_article
Evidence Source 2022 PMID: 35834523
Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2021 PMID: 32458316
The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review pubmed_article
Evidence Source 2021 PMID: 33354748
Real-world comparison of direct-acting oral anticoagulants and vitamin K antagonists in chronic kidney disease: a systematic review and meta-analysis pubmed_article
Evidence Source 2021 PMID: 33949923
Comparison of outcomes of direct-acting oral anticoagulants vs. vitamin K antagonists in patients with bioprosthetic heart valves or valve repair: a systematic review and meta-analysis pubmed_article
Evidence Source 2021 PMID: 34355372
Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis pubmed_article
Evidence Source 2021 PMID: 34462932
Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis pubmed_article
Evidence Source 2020 PMID: 31792707
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2020 PMID: 32206988
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome pubmed_article
Evidence Source 2020 PMID: 33045766
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2019 PMID: 31310583
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis pubmed_article
Evidence Source 2018 PMID: 29030422
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation pubmed_article
Evidence Source 2018 PMID: 29509959
Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia pubmed_article
Evidence Source 2018 PMID: 30582172
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome pubmed_article
Evidence Source 2017 PMID: 28968483
Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis pubmed_article
Evidence Source 2016 PMID: 26797248
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism pubmed_article
Evidence Source 2015 PMID: 26636644
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation pubmed_article
Evidence Source 2013 PMID: 23925867

Evidence Search Results semantic · quality-ranked

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair meta_analysis pubmed_article
Quality: 77 2025 PMID: 39868562 DOI: 10.1002/14651858.CD011762.pub2
SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis meta_analysis pubmed_article
Quality: 65 2024 PMID: 38252269 DOI: 10.1007/s40256-023-00623-3
Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis meta_analysis pubmed_article
Quality: 64 2024 PMID: 38353592 DOI: 10.1097/CCM.0000000000006212
An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis systematic_review pubmed_article
Quality: 64 2023 PMID: 37703679 DOI: 10.1016/j.amjcard.2023.07.141
Meta-analysis of modifiable risk factors for Alzheimer's disease meta_analysis pubmed_article
Quality: 54 2015 PMID: 26294005 DOI: 10.1136/jnnp-2015-310548
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials meta_analysis pubmed_article
Quality: 54 2017 PMID: 28265017 DOI: 10.1161/STROKEAHA.116.015984
Prevention of nNon-Vitamin K Oral Anticoagulants-Related Gastrointestinal Bleeding With Acid Suppressants: A Systematic Review and Meta-Analysis meta_analysis pubmed_article
Quality: 52 2022 PMID: 35037779 DOI: 10.1177/10760296211064897
Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia meta_analysis pubmed_article
Quality: 72 2018 PMID: 30582172 DOI: 10.1002/14651858.CD010649.pub2
ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction clinical_trial clinical_trial
Quality: 46 2025 NCT: NCT06856590
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis meta_analysis pubmed_article
Quality: 74 2023 PMID: 37058421 DOI: 10.1002/14651858.CD010956.pub3
**Wang et al., 2023** | Cochrane Database Syst Rev | Meta Analysis Wang Xiaoqin, Ma Yanfang, ... Yao Liang. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagula...

View full evidence search →